Your browser doesn't support javascript.
loading
Microglia used as vehicles for both inducible thymidine kinase gene therapy and MRI contrast agents for glioma therapy.
Ribot, E; Bouzier-Sore, A-K; Bouchaud, V; Miraux, S; Delville, M-H; Franconi, J-M; Voisin, P.
Affiliation
  • Ribot E; Centre de Résonance Magnétique des Systèmes Biologiques, UMR 5536, CNRS-Université V. Segalen, Bordeaux, France. ribot@rmsb.u-bordeaux2.fr
Cancer Gene Ther ; 14(8): 724-37, 2007 Aug.
Article in En | MEDLINE | ID: mdl-17541423
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thymidine Kinase / Magnetic Resonance Imaging / Genetic Therapy / Microglia / Contrast Media / Glioma Limits: Animals / Female / Humans Language: En Journal: Cancer Gene Ther Journal subject: GENETICA MEDICA / NEOPLASIAS / TERAPEUTICA Year: 2007 Document type: Article Affiliation country: Francia Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thymidine Kinase / Magnetic Resonance Imaging / Genetic Therapy / Microglia / Contrast Media / Glioma Limits: Animals / Female / Humans Language: En Journal: Cancer Gene Ther Journal subject: GENETICA MEDICA / NEOPLASIAS / TERAPEUTICA Year: 2007 Document type: Article Affiliation country: Francia Country of publication: Reino Unido